BLACKROCK HEALTH SCI TR II

BLACKROCK HEALTH SCI TR II (BMEZ)

$15.83

+0.04

(+0.25%)

Market is closed - opens 7 PM, 30 May 2023

Performance

  • $15.81
    $15.96
    $15.83
    downward going graph

    0.1%

    Downside

    Day's Volatility :0.92%

    Upside

    0.81%

    downward going graph
  • $13.40
    $16.65
    $15.83
    downward going graph

    15.35%

    Downside

    52 Weeks Volatility :19.52%

    Upside

    4.92%

    downward going graph

Returns

PeriodBLACKROCK HEALTH SCI TR IIRussel 2000Index (Russel 2000)
3 Months
-0.5%
-6.7%
-6.7%
6 Months
-0.25%
-3.7%
-3.7%
1 Year
-5.32%
-6.3%
-6.3%
3 Years
-21.56%
26.9%
26.9%

Highlights

Market Capitalization
1.7B
Dividend Share
0.0
Dividend Yield
11.02%
Earnings Per Share (EPS)
-5.9
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-5.9
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

BLACKROCK HEALTH SCI TR II is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
BLACKROCK HEALTH SCI TR II
BLACKROCK HEALTH SCI TR II
-3.71%
-0.25%
-5.32%
-21.56%
-21.01%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
BLACKROCK HEALTH SCI TR II
BLACKROCK HEALTH SCI TR II
NA
NA
NA
0.0
0.0
0.0
0.11
NA
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
BLACKROCK HEALTH SCI TR II
BLACKROCK HEALTH SCI TR II
NA
$1.7B
-21.01%
NA
0.0%

Corporate Announcements

  • BLACKROCK HEALTH SCI TR II Earnings

    BLACKROCK HEALTH SCI TR II’s price-to-earnings ratio stands at None

    Read More

Company Information

BlackRock Health Sciences Trust II’s (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust’s risk-adjusted returns.

Organization
BLACKROCK HEALTH SCI TR II
Employees
0
CEO
Mr. Jeffrey Gene Lee
Industry
Miscellaneous

FAQs